BlackRock’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.7M | Sell |
|
|||||
|
2025
Q1 | $3.41M | Sell |
|
|||||
|
2024
Q4 | $10.6M | Buy |
|
|||||
|
2024
Q3 | $18.3M | Buy |
|
|||||
|
2024
Q2 | $14.9M | Buy |
|
|||||
|
2024
Q1 | $23.7M | Buy |
|
|||||
|
2023
Q4 | $13M | Buy |
|
|||||
|
2023
Q3 | $9.41M | Buy |
|
|||||
|
2023
Q2 | $10.8M | Buy |
|
|||||
|
2023
Q1 | $2.59M | Buy |
|
|||||
|
2022
Q4 | $448K | Sell |
|
|||||
|
2022
Q3 | $1.15M | Sell |
|
|||||
|
2022
Q2 | $2.05M | Sell |
|
|||||
|
2022
Q1 | $3.59M | Buy |
|
|||||
|
2021
Q4 | $5.71M | Sell |
|
|||||
|
2021
Q3 | $10.4M | Buy |
|
|||||
|
2021
Q2 | $15.3M | Buy |
|
|||||
|
2021
Q1 | $17.1M | Buy |
|
|||||
|
2020
Q4 | $13M | Buy |
|
|||||
|
2020
Q3 | $13.2M | Buy |
|